Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Chronic Therapy
Premium
But a fall in doctor visits hit acute therapy drugs. July saw a major turnaround
Premium
Top pharma companies will continue to face severe pricing pressure and regulatory overhang in FY18